论文信息 - Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional‐Cell Carcinoma - 字舞流文

Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional‐Cell Carcinoma

M. Hurwitz | D. Petrylak | Jaymin D. Patel | W. Kelly | M. Stein | A. Mortazavi | J. Mehnert | H. Deshpande | X. Yao | P. Markowski | A. Donadio | Xiaopan Yao | Jaymin Patel